SMARCA1 and neoplasm: The mesenchymal-like group was associated with advanced-stage, higher-enrichment of immune-related pathway and poor survival, while the epithelial-like was related to early-stage tumour, a higher frequency of SWI/SNF complex mutations and favourable outcome [16].